Press Release
20 june 2007
BioGaia's employee incentive scheme
The Annual General Meeting of BioGaia AB in April 2007 resolved to carry out a
share-based incentive scheme for the employees. In connection with this, it was
decided that warrants would be issued in a number of not more than 200,000 and
that the subscription period for the warrants would run from 15 May 2007 to 15
June 2007 inclusive.
The employees subscribed for a total of 128,950 warrants, resulting in a
dilution effect of approximately 0.7% in the total number of shares outstanding
and 0.5% in the total number of votes. The remaining warrants have been set
aside for future use.
Each warrant gives the holder the right to subscribe for one class B share for a
price of SEK 76.70 during the period from 15 May 2010 to 31 August 2010
inclusive. The warrant price was calculated according to the customary valuation
method (Black & Scholes model) and amounted to SEK 5.32 per warrant.
Latest press releases from BioGaia:
2007-06-12 BioGaia signs agreement with a company in the Otsuka group for dog
product
2007-04-25 Annual General Meeting of BioGaia
2007-04-24 BioGaia AB Interim Report 1 January - 31 March 2007
For additional information contact:
Peter Rothschild, Managing Director, telephone: +46 8 - 555 293 00,
Jan
Annwall, Deputy Managing Director telephone: +46 8 - 555 293 00
--------------------------------------------------------------------------------
---------------------------------------------------------------
BioGaia is a biotechnology company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic,
health-enhancing effects. The class B share of the Parent Company BioGaia AB is
quoted on the Small Cap list of the Nordic Stock Exchange in Stockholm.
www.biogaia.com